http://www.fpnotebook.com/
QuetiapineAka: Seroquel
- Class
- Atypical Antipsychotic (Second Generation agent)
- Neuroleptic
- Dibenzothiazepine Antipsychotic
- Indications
- Schizophrenia
- Psychosis in Dementia
- Mania (not FDA approved)
- Bipolar Disorder (not FDA approved)
- Autism (not FDA approved)
- Insomnia (not FDA approved)
- Dosing
- Adults
- Initial: 25 mg PO bid-tid
- Increase in 25-50 mg/day increments
- Target: 300-400 mg/day divided bid-tid
- Maximum dose: 750 mg/day
- Elderly
- Initial dose: 12.5 mg PO qhs
- Titrate up every few days (caution due to Sedation)
- Adults
- Adverse Effects
- Sedation
- Headache
- Orthostatic Hypotension
- Cataract formation
- Drug Interactions
- Increase Antipsychotic levels (toxicity risk): Monitor for toxicity
- Decrease Antipsychotic levels (lower efficacy)
- Barbiturates
- Carbamazepine
- Phenytoin
- Rifampin
- Theophylline
- Other effects
- Avoid concurrent use of other medications prolonging QT Interval
- Monitoring
- See Antipsychotic
- Screen for Cataract formation every 6 months
- Consider EKG, electrolyte and Magnesium monitoring due to QT Interval prolongation risk
- Pharmacokinetics
- Metabolized by Cytochrome P450 3A4
quetiapine (C0123091) | |
|---|---|
| Definition (NCI) | A dibenzothiazepine derivative with antipsychotic property. Quetiapine fumarate antagonizes serotonin activity mediated by 5-HT 1A and 5-HT2 receptors. With a lower affinity, this agent also reversibly binds to dopamine D1 and D2 receptors in the mesolimbic and mesocortical areas of the brain leading to decreased psychotic effects, such as hallucinations and delusions. In addition, quetiapine also binds to other alpha-1, alpha-2 adrenergic and histamine H1 receptors. |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | C069541 |
| English | quetiapine, QUETIAPINE PREPARATION |
| Spanish | quetiapina |
| Parent Concepts | Serotonin Antagonists (C0036753), Antipsychotic Agents (C0040615), Dibenzothiazepines (C0012033), [CN709] ANTIPSYCHOTICS, OTHER (C0973508), Dibenzoxazepine derivative antipsychotic agent (C0304389), Atypical antipsychotic (C1276996), Mood stabilizing drug (C1276998), Drug allergen (C1320237), Non-phenothiazines/ Atypicals (C1579416) |
| Sources | LNC, MSH, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Seroquel (C0287163) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | C069541 |
| English | AstraZeneca Brand of Quetiapine Fumarate, Seroquel, Zeneca Brand of Quetiapine Fumarate |
| Sources | MSH, MTH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
